Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

JBM (Healthcare) Ltd. (2161) Stock Price & Analysis

4 Followers

2161 Stock Chart & Stats

HK$1.58HK$0.00(-1.87%)
At close: 4:00 PM GMT+8
HK$1.5HK$1.75Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
HKD 1.54 - HKD 1.59
52-Week Range
HKD 1.48 - HKD 3.11
Previous Close
HKD 1.61
Volume
N/A
Average Volume (3M)
268.45K
Market Cap
HKD 1.29B
Enterprise Value
HKD 2.49B
Total Cash (Recent Filing)
HKD 119.94M
Total Debt (Recent Filing)
HKD 393.72M
Price to Earnings (P/E)
6.3
Beta
0.26
Next Earnings
Nov 20, 2026 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Sep 07, 2026
Dividend Yield
10.85%

Bulls Say, Bears Say

Bulls Say

Revenue Scale

Revenue more than doubled across the period, demonstrating meaningful business scale and sustained commercial expansion. A larger revenue base can support operating leverage, broader market reach, and continued investment in the company’s healthcare portfolio over the next several quarters.

Margin Expansion

The substantial improvement in gross and net margins indicates stronger earnings quality and improved profitability as the business has scaled. Higher margins can provide greater resilience, fund product and commercial investment, and support durable earnings generation if broadly maintained.

Capital Efficiency

ROE rising to 18.6% signals materially better use of shareholder capital than in earlier years. Combined with a sizable equity base, this suggests improved capital efficiency and a stronger foundation for financing growth while retaining balance-sheet support.

Bears Say

Higher Leverage

The sharp increase in debt relative to equity reduces financial flexibility compared with the prior two years. Higher leverage can increase the importance of maintaining operating profitability and cash generation, while limiting room for additional investment or capital allocation during weaker periods.

Free Cash Flow Decline

Although free cash flow remained positive, its sizeable year-over-year decline indicates that less internally generated cash was available after investment and operating requirements. Persistently weaker cash conversion could constrain debt reduction, reinvestment, and shareholder distributions.

Margin Normalization

The modest 2026 easing in operating margins is a negative signal after the company’s pronounced profitability expansion. If this normalization continues, it could slow earnings growth and reduce the operating leverage expected from the company’s larger revenue base.

JBM (Healthcare) Ltd. News

2161 FAQ

What was JBM (Healthcare) Ltd.’s price range in the past 12 months?
JBM (Healthcare) Ltd. lowest stock price was HK$1.48 and its highest was HK$3.11 in the past 12 months.
What is JBM (Healthcare) Ltd.’s market cap?
JBM (Healthcare) Ltd.’s market cap is HK$1.29B.
When is JBM (Healthcare) Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were JBM (Healthcare) Ltd.’s earnings last quarter?
JBM (Healthcare) Ltd. released its earnings results on Jun 22, 2026. The company reported HK$0.106 earnings per share for the quarter.
Is JBM (Healthcare) Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does JBM (Healthcare) Ltd. pay dividends?
JBM (Healthcare) Ltd. pays a semiannual dividend of HK$0.074 which represents an annual dividend yield of 10.85%. See more information on JBM (Healthcare) Ltd. dividends here
What is JBM (Healthcare) Ltd.’s EPS estimate?
JBM (Healthcare) Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does JBM (Healthcare) Ltd. have?
JBM (Healthcare) Ltd. has 822,000,000 shares outstanding.
What happened to JBM (Healthcare) Ltd.’s price movement after its last earnings report?
JBM (Healthcare) Ltd. reported an EPS of HK$0.106 in its last earnings report. Following the earnings report the stock price went down -0.409%.
Which hedge fund is a major shareholder of JBM (Healthcare) Ltd.?
Currently, no hedge funds are holding shares in HK:2161
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology